Format

Send to

Choose Destination

See 1 citation found using an alternative search:

Perit Dial Int. 1993;13(3):219-23.

Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid.

Author information

1
Manchester Royal Infirmary Renal Unit, United Kingdom.

Abstract

OBJECTIVE:

To examine the effect of a reduced calcium/magnesium dialysis fluid (1.25/0.25 mmol/L, respectively) on calcium and magnesium mass transfer in both 1.36% and 3.86% glucose solutions.

DESIGN:

Each patient underwent four test exchanges, two with a standard dialysis fluid containing 1.36% and 3.86% glucose, and two with a reduced calcium/magnesium fluid containing 1.36% and 3.86% glucose. Calcium and magnesium were measured in dialysate and serum at 0 and 240 minutes.

SETTING:

Single renal unit of a university teaching hospital.

PATIENTS:

Sixteen patients established on CAPD, and peritonitis-free, for at least 3 months.

RESULTS:

A lower dialysate calcium results in negative mass transfer when serum-ionized calcium exceeds dialysate calcium (mean -0.21 +/- 0.15 mmol/exchange), and positive mass transfer when serum-ionized calcium is less than dialysate calcium in 1.36% glucose solutions (mean 0.57 +/- 0.18 mmol/exchange). A negative correlation was found between serum-ionized calcium level and calcium mass transfer. With a 3.86% reduced calcium/magnesium solution, calcium mass transfer is always negative (-0.88 +/- 0.18 mmol/exchange) due to ultrafiltration and solute drag. Fifteen patients were found to be hypermagnesemic at the time of the study. Magnesium mass transfer was neutral with the standard 1.36% glucose fluid (mean -0.01 mmol/exchange), but negative with the reduced calcium/magnesium 1.36% glucose fluid (mean -0.58 +/- 0.13 mmol/exchange). With the 3.86% glucose solution, both fluids produced negative magnesium mass transfer (mean -0.32 +/- 0.11 and -1.07 +/- 0.11 mmol/exchange for standard and reduced calcium/magnesium fluids, respectively).

CONCLUSIONS:

We conclude that this fluid formulation should reduce hypercalcemia and hypermagnesemia in CAPD patients.

PMID:
8369353
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center